Cargando…
Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer
BACKGROUND: Use of exosomes as biomarkers in non‐small cell lung cancer (NSCLC) is an intriguing approach in the liquid‐biopsy era. Exosomes are nano‐sized vesicles with membrane‐bound proteins that reflect their originating cell. Prognostic biomarkers are needed to improve patient selection for opt...
Autores principales: | Sandfeld-Paulsen, B., Aggerholm-Pedersen, N., Bæk, R., Jakobsen, K.R., Meldgaard, P., Folkersen, B.H., Rasmussen, T.R., Varming, K., Jørgensen, M.M., Sorensen, B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423137/ https://www.ncbi.nlm.nih.gov/pubmed/27856179 http://dx.doi.org/10.1016/j.molonc.2016.10.003 |
Ejemplares similares
-
Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations()
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2016) -
Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma
por: Jakobsen, Kristine R., et al.
Publicado: (2015) -
Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
por: Winther-Larsen, Anne, et al.
Publicado: (2021) -
Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2021) -
Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients
por: Winther-Larsen, Anne, et al.
Publicado: (2022)